⌘K

Login Start Free

Home/Filings/4/0001213900-25-050110

4//SEC Filing

Pierce Kristen 4

Accession 0001213900-25-050110

CIK 0001870404other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:01 PM ET

Size

5.6 KB

Accession

0001213900-25-050110

Insider Transaction Report

Form 4

Period: 2025-05-30

CERO THERAPEUTICS HOLDINGS, INC.CERO

Chief Development Officer

Transactions

Award
Stock Option (Right to Buy)
2025-05-30+154,841→ 154,841 total
Exercise: $0.45Exp: 2035-05-29→ Common Stock (154,841 underlying)

Footnotes (1)

[F1]The shares underlying this option shall vest in equal monthly installments through June 4, 2027.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1

filerCIK 0002039649

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 5:01 PM ET
Size: 5.6 KB

View on SEC.gov